Data gathered: March 6
Alternative Data for Invivyd
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 5 | Sign up | Sign up | Sign up |
| Sentiment | 79 | Sign up | Sign up | Sign up |
| Webpage traffic | 5,000 | Sign up | Sign up | Sign up |
| Employee Rating | 56 | Sign up | Sign up | Sign up |
| Google Trends | 15 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 4,796 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,233 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 21 | Sign up | Sign up | Sign up |
| Linkedin Employees | 113 | Sign up | Sign up | Sign up |
About Invivyd
Invivyd, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
| Price | $1.06 |
| Target Price | Sign up |
| Volume | 3,520,000 |
| Market Cap | $126M |
| Year Range | $0.36 - $2.11 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Invivyd announces in vitro neutralization data for PEMGARDAMarch 5 - Thefly.com |
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1March 5 - GlobeNewswire |
|
Why Invivyd, Inc. (IVVD) is Skyrocketing So Far in 2025March 2 - Yahoo Entertainment |
|
 |
Invivyd (NASDAQ:IVVD) Earns “Buy” Rating from HC WainwrightFebruary 26 - ETF Daily News |
|
Invivyd’s (IVVD) “Buy” Rating Reaffirmed at D. Boral CapitalFebruary 25 - ETF Daily News |
 |
FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised PatientsFebruary 24 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 9.3M | 13M | -3.7M | -61M | -62M | -0.510 |
| Q2 '24 | 2.3M | 21M | -19M | -47M | -49M | -0.400 |
| Q1 '24 | 0 | 15M | -15M | -43M | -46M | -0.380 |
| Q4 '23 | 3M | 15M | -15M | -74M | -77M | -0.670 |
| Q3 '23 | 0 | 13M | -13M | -39M | -43M | -0.360 |
Insider Transactions View All
| MCGUIRE TERRANCE filed to sell 3,066,757 shares at $0.4. December 31 '24 |
| MCGUIRE TERRANCE filed to sell 3,170,231 shares at $0.5. December 31 '24 |
| MCGUIRE TERRANCE filed to sell 3,256,776 shares at $0.5. December 31 '24 |
| MCGUIRE TERRANCE filed to sell 3,340,520 shares at $0.5. December 26 '24 |
| MCGUIRE TERRANCE filed to sell 3,424,337 shares at $0.5. December 26 '24 |
Similar companies
Read more about Invivyd (IVVD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Invivyd?
The Market Cap of Invivyd is $126M.
What is the current stock price of Invivyd?
Currently, the price of one share of Invivyd stock is $1.06.
How can I analyze the IVVD stock price chart for investment decisions?
The IVVD stock price chart above provides a comprehensive visual representation of Invivyd's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Invivyd shares. Our platform offers an up-to-date IVVD stock price chart, along with technical data analysis and alternative data insights.
Does IVVD offer dividends to its shareholders?
As of our latest update, Invivyd (IVVD) does not offer dividends to its shareholders. Investors interested in Invivyd should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Invivyd?
Some of the similar stocks of Invivyd are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.